Frank C. Eisenschenk

Array ( [id] => 3941100 [patent_doc_number] => 05872222 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants' [patent_app_type] => 1 [patent_app_number] => 7/993291 [patent_app_country] => US [patent_app_date] => 1992-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3828 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872222.pdf [firstpage_image] =>[orig_patent_app_number] => 993291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3017927 [patent_doc_number] => 05340923 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-23 [patent_title] => 'Methods for making and purifying antivenoms' [patent_app_type] => 1 [patent_app_number] => 7/977583 [patent_app_country] => US [patent_app_date] => 1992-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 35337 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/340/05340923.pdf [firstpage_image] =>[orig_patent_app_number] => 977583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2986317 [patent_doc_number] => 05250666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-05 [patent_title] => 'Radionuclide metal chelates for the radiolabeling of proteins' [patent_app_type] => 1 [patent_app_number] => 7/973048 [patent_app_country] => US [patent_app_date] => 1992-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10158 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/250/05250666.pdf [firstpage_image] =>[orig_patent_app_number] => 973048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2945198 [patent_doc_number] => 05254671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-19 [patent_title] => 'Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor' [patent_app_type] => 1 [patent_app_number] => 7/973321 [patent_app_country] => US [patent_app_date] => 1992-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12641 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/254/05254671.pdf [firstpage_image] =>[orig_patent_app_number] => 973321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810573 [patent_doc_number] => 05854400 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Monoclonal antibodies which neutralize HIV-1 infection' [patent_app_type] => 1 [patent_app_number] => 7/950571 [patent_app_country] => US [patent_app_date] => 1992-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 14643 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854400.pdf [firstpage_image] =>[orig_patent_app_number] => 950571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059704 [patent_doc_number] => 05864008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides' [patent_app_type] => 1 [patent_app_number] => 7/921447 [patent_app_country] => US [patent_app_date] => 1992-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5574 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864008.pdf [firstpage_image] =>[orig_patent_app_number] => 921447 [rel_patent_id] =>[rel_patent_doc_number] =>)